Guardant Health [GH] vs Thermo Fisher [TMO] Detailed Stock Comparison
Guardant Health
NASDAQ
Loading...
Thermo Fisher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Guardant Health wins in 8 metrics, Thermo Fisher wins in 10 metrics, with 0 ties. Thermo Fisher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Guardant Health | Thermo Fisher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -15.23 | 26.66 | Guardant Health |
| Price-to-Book Ratio | -22.03 | 3.44 | Guardant Health |
| Debt-to-Equity Ratio | -4.37 | 69.62 | Guardant Health |
| PEG Ratio | -20.01 | 19.61 | Guardant Health |
| EV/EBITDA | -18.07 | 18.76 | Guardant Health |
| Profit Margin (TTM) | -49.93% | 15.24% | Thermo Fisher |
| Operating Margin (TTM) | -45.75% | 17.84% | Thermo Fisher |
| EBITDA Margin (TTM) | N/A | 17.84% | N/A |
| Return on Equity | 312.48% | 13.42% | Guardant Health |
| Return on Assets (TTM) | -19.57% | 4.97% | Thermo Fisher |
| Free Cash Flow (TTM) | $-274.94M | $7.27B | Thermo Fisher |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | 87.00% | -22.72% | Guardant Health |
| Price-to-Sales Ratio (TTM) | 8.16 | 4.03 | Thermo Fisher |
| Enterprise Value | $7.57B | $202.90B | Thermo Fisher |
| EV/Revenue Ratio | 9.14 | 4.70 | Thermo Fisher |
| Gross Profit Margin (TTM) | 65.01% | 40.61% | Guardant Health |
| Revenue per Share (TTM) | $7 | $114 | Thermo Fisher |
| Earnings per Share (Diluted) | $-3.35 | $17.28 | Thermo Fisher |
| Beta (Stock Volatility) | 1.44 | 0.75 | Thermo Fisher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Guardant Health vs Thermo Fisher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Guardant Health | 7.62% | 30.93% | 6.71% | 30.11% | 22.14% | 70.70% |
| Thermo Fisher | 1.32% | -0.50% | 8.11% | 12.16% | -16.67% | -11.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Guardant Health | 87.00% | 0.09% | -36.54% | 85.72% | 85.72% | 85.72% |
| Thermo Fisher | -22.72% | -23.62% | 11.35% | 241.22% | 940.00% | 1,501.39% |
Performance & Financial Health Analysis: Guardant Health vs Thermo Fisher
| Metric | GH | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $6.76B | $173.97B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 4,168,170 | 2,513,510 |
| 90 Day Avg. Volume | 2,645,913 | 3,050,043 |
| Last Close | $54.23 | $460.72 |
| 52 Week Range | $20.14 - $54.62 | $385.46 - $627.88 |
| % from 52W High | -0.71% | -26.62% |
| All-Time High | $181.07 (Feb 08, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -70.05% | -31.48% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.03% |
| Quarterly Earnings Growth | 0.31% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.50% | 0.15% |
| Operating Margin (TTM) | -0.46% | 0.18% |
| Return on Equity (TTM) | 3.12% | 0.13% |
| Debt to Equity (MRQ) | -4.37 | 69.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-2.45 | $133.77 |
| Cash per Share (MRQ) | $4.19 | $16.92 |
| Operating Cash Flow (TTM) | $-238,546,000 | $7.58B |
| Levered Free Cash Flow (TTM) | $-131,174,000 | $5.18B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | $1.21 |
Valuation & Enterprise Metrics Analysis: Guardant Health vs Thermo Fisher
| Metric | GH | TMO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -15.23 | 26.66 |
| Forward P/E | -20.01 | 19.61 |
| PEG Ratio | -20.01 | 19.61 |
| Price to Sales (TTM) | 8.16 | 4.03 |
| Price to Book (MRQ) | -22.03 | 3.44 |
| Market Capitalization | ||
| Market Capitalization | $6.76B | $173.97B |
| Enterprise Value | $7.57B | $202.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.14 | 4.70 |
| Enterprise to EBITDA | -18.07 | 18.76 |
| Risk & Other Metrics | ||
| Beta | 1.44 | 0.75 |
| Book Value per Share (MRQ) | $-2.45 | $133.77 |
Financial Statements Comparison: Guardant Health vs Thermo Fisher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GH | TMO |
|---|---|---|
| Revenue/Sales | $203.47M | $10.36B |
| Cost of Goods Sold | $74.72M | $6.13B |
| Gross Profit | $128.75M | $4.24B |
| Research & Development | $88.52M | $342.00M |
| Operating Income (EBIT) | $-111.04M | $1.82B |
| EBITDA | $-83.84M | $2.73B |
| Pre-Tax Income | $-94.87M | $1.62B |
| Income Tax | $290,000 | $95.00M |
| Net Income (Profit) | $-95.16M | $1.51B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GH | TMO |
|---|---|---|
| Cash & Equivalents | $698.57M | $4.13B |
| Total Current Assets | $927.03M | $23.38B |
| Total Current Liabilities | $225.75M | $13.17B |
| Long-Term Debt | $1.28B | $31.37B |
| Total Shareholders Equity | $-250.79M | $49.49B |
| Retained Earnings | $-2.67B | $54.45B |
| Property, Plant & Equipment | $140.50M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GH | TMO |
|---|---|---|
| Operating Cash Flow | $-49.41M | $2.15B |
| Capital Expenditures | $-4.46M | $-350.00M |
| Free Cash Flow | $-67.15M | $361.00M |
| Debt Repayment | N/A | $-838.00M |
| Common Stock Repurchase | $-45.01M | $-2.00B |
Short Interest & Institutional Ownership Analysis
| Metric | GH | TMO |
|---|---|---|
| Shares Short | 9.58M | 3.83M |
| Short Ratio | 4.80 | 1.39 |
| Short % of Float | 0.08% | 0.01% |
| Average Daily Volume (10 Day) | 4,168,170 | 2,513,510 |
| Average Daily Volume (90 Day) | 2,645,913 | 3,050,043 |
| Shares Outstanding | 123.99M | 380.77M |
| Float Shares | 119.55M | 376.79M |
| % Held by Insiders | 0.05% | 0.00% |
| % Held by Institutions | 0.99% | 0.93% |
Dividend Analysis & Yield Comparison: Guardant Health vs Thermo Fisher
| Metric | GH | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.21 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | $1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.07% |
| 3-Year Total Dividends | N/A | $3.99 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |